We are currently seeking a company to buy or partner and market BONISARA - a Novel Treatment for Osteoporosis More

Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More

New local approach in Osteoarthritis: INTRA-ARTICULAR CLODRONATE More

Identification and use of RAR antagonists to induce bone and cartilage formation More

Alendronate 70mg Once Weekly Tablets More

Highly effective anabolic treatment of periodontal bony defects with novel prostaglandin E1 complex. More

HU-308, a synthetic cannabinoid has demonstrated in vivo anti-osteoporotic efficacy of agonist highly specific for CB2 that concomitantly restrains bone resorption and stimulates bone formation. HU-308 has no psychotropic or anti-annorexigenic... More

The advantage of this drug delivery system is the ability to directly target specific skeletal sites of disease, while also being able to administer the lowest, clinically effective dose possible, thereby lowering the potential for harmful side effec More